Statistics for GLP-1 and dual GIP/GLP-1 receptor agonists in overweight/obese patients for atherosclerotic cardiovascular disease prevention: Where are we now?

Total visits

views
GLP-1 and dual GIP/GLP-1 receptor agonists in overweight/obese patients for atherosclerotic cardiovascular disease prevention: Where are we now? 0

Total visits per month

views
May 2024 0
June 2024 0
July 2024 0
August 2024 0
September 2024 0
October 2024 0
November 2024 0